Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Slides:



Advertisements
Similar presentations
Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.
Advertisements

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.
Upfront Combination Therapy vs Step-Up Approach for PAH:
The Patient Experience With Systemic Lupus Erythematosus
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
The Nurse View: Management of Pancreatic Cancer
HIV-Associated Weight Loss and Wasting
Assessing COPD in Primary Care
Advances in Managing Inhibitors in Patients With Hemophilia A
Essential Updates in Atopic Dermatitis:
Does One Size Fit All in Obesity Management?
Progression After Cancer Immunotherapy in Advanced NSCLC
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
Current Controversies in Multiple Sclerosis Management
Charting Progress in MS Diagnosis and Treatment for Today and Tomorrow
The HCV Revolution: Are You and Your Practice Ready?
The Latest Data on Oral Prostacyclin Therapy in PAH
PCP Perspectives Clinical Considerations in Hyperkalemia
Advances in Dry Eye.
Goals of Therapy in Relapsed CLL
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and Emerging Treatments.
Chronic Idiopathic Urticaria
The Nurse View: Best Practices in Multiple Myeloma
Program Introduction. Monoclonal Antibodies and Immunogenicity: Relevance to Clinical Practice?
Precision Management of RA and Comorbidities
Multidisciplinary Perspectives on Interstitial Lung Diseases
WHO Clinical Classification of PH Complex Cases in PH.
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
Management of Adolescents With Seizures
Practical Guidance on Using New Therapies for Relapsed/ Refractory Follicular Lymphoma and Chronic Lymphocytic Leukemia.
Gene Therapy: Past, Present, and Future
Atopic Dermatitis. Introduction to a Clinical Course On New Developments In Atopic Dermatitis.
Demographics of IPF in the USa-d
Tackling Atopic Dermatitis
Immunotherapy for cSCC
Diagnosing Focal Epilepsy: A Clinical Case
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
What Is Bipolar Disorder?
Managing Polycythemia Vera in the Community Setting
Personalizing Management in the Care of Patients With Advanced Sarcoma
Management of Systematic Lupus Erythematosus
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Understanding and Addressing the Needs of Patients With AD
Treatment-Resistant Schizophrenia
Battling the Flu: Latest Advances in the Influenza Treatment Arsenal
Application of Biosimilars in RA IN Clinical Practice: Key Issues and Challenges  
Challenges in Severe Asthma
EGPA.
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
Severe Asthma and Comorbidities
Insulin in Diabetes Management: Effective Patient Selection Is Key
Possible Causes of imAEs
Incorporating Prostacyclins Into Practice
Challenges in LA SCCHN.
THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES
Program Goal. Program Goal Disclaimer Overview.
Prostacyclin Pathway Agents in Action
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
How to Select Therapy in Relapsed/Refractory CLL
MS, Age, and Immune Function
The Building Blocks of Homocystinuria and Homocysteinemia Management
Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia.
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
Ask the Psoriasis Expert
Comprehensive Acne Management
Exploring the Role of Biologics in Reducing Oral Corticosteroid Use in Severe Asthma.
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
What's New in NOACs in AF?.
Presentation transcript:

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice

Pemphigus Vulgaris Introduction

Monitoring Treatment Response

Case 1 Nikki

Physical Examination

Physical Examination (Cont.)

Assessment and Treatment Plan

Diagnosis

Supportive Care and Topical Treatment

Case 1 (Cont.)

Goals of Therapeutic Management of PV

Case 1 Discussion of Treatment Options

General Health Assessment

Managing Corticosteroid Treatment Adverse Events

Managing PV Special Considerations

Case 2 Rita

Rita Past Medical History

Clinical Presentation

Diagnostic Considerations

Therapeutic Options for PV

Rituximab A New Treatment Option in PV

Rituximab Ritux 3 Trial Design

Ritux 3 Trial Results

Therapeutic Considerations Comorbidities

Case 3 Kenny

Case 3 (Cont.)

Emerging Targets B Cells

Emerging Targets T Cells

Emerging Targets Antibody

Concluding Remarks

Abbreviations

Abbreviations (cont)